Metraipolis › archive › dc_a4e32f4a5142

Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb — Europe PMC PMID:36683157

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36683157
DOI
10.1080/19420862.2022.2160227
License (as archived)
CC0-1.0
Archived
2026-10-08T06:08:58.296Z
SHA-256 of the archived text
204852ab07e7f3e6f69c415c9c3a6ff4a4c0405aa364a27467ccf6506d2737ce
Stable URL of this page
https://metraipolis.com/documento/dc_a4e32f4a5142

How to cite

Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb — Europe PMC PMID:36683157 — Europe PMC (en), https://europepmc.org/article/MED/36683157 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_a4e32f4a5142 (Metraipolis archive dc_a4e32f4a5142, sha256 204852ab07e7f3e6f69c415c9c3a6ff4a4c0405aa364a27467ccf6506d2737ce)
BibTeX
@misc{dca4e32f4a5142,
  title = {Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb — Europe PMC PMID:36683157},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36683157},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_a4e32f4a5142; sha256 204852ab07e7f3e6f69c415c9c3a6ff4a4c0405aa364a27467ccf6506d2737ce},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36683157. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

The clinical efficacy and safety of protein-based drugs such as monoclonal antibodies (mAbs) rely on the integrity of the protein higher order structure (HOS) during product development, manufacturing, storage, and patient administration. As mAb-based drugs are becoming more prevalent in the treatment of many illnesses, the need to establish metrics for quality attributes of mAb therapeutics through high-resolution techniques is also becoming evident. To this end, here we used a forced degradation method, time-dependent oxidation by hydrogen peroxide, on the model biotherapeutic NISTmAb and evaluated the effects on HOS with orthogonal analytical methods and a functional assay. To monitor the oxidation process, the experimental workflow involved incubation of NISTmAb with hydrogen peroxide in a benchtop nuclear magnetic resonance spectrometer (NMR) that followed the reaction kinetics, in real-time through the water proton transverse relaxation rate R 2 ( 1 H 2 O). Aliquots taken at defined time points were further analyzed by high-field 2D 1 H- 13 C methyl correlation fingerprint spectra in parallel with other analytical techniques, including thermal unfolding, size-exclusion chromatography, and surface plasmon resonance, to assess changes in stability, heterogeneity, and binding affinities. The complementary measurement outputs from the different techniques demonstrate the utility of combining NMR with other analytical tools to monitor oxidation kinetics and extract the resulting structural changes in mAbs that are functionally relevant, allowing rigorous assessment of HOS attributes relevant to the efficacy and safety of mAb-based drug products.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: mAbs, 2023 (prima pubblicazione 2023-01-01).
Identificativi: PMID 36683157 · PMCID PMC9872951 · DOI 10.1080/19420862.2022.2160227.
Parole chiave degli autori: Surface plasmon resonance; 2D NMR; Biologics; Antigen Binding; Higher Order Structure; Nistmab; Low-field Water Nmr Relaxometry.
Descrittori MeSH principali: Hydrogen Peroxide; Antibodies, Monoclonal.
Pagina: https://europepmc.org/article/MED/36683157 — https://doi.org/10.1080/19420862.2022.2160227. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-08T05:35:51.002Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.